Standard BioTools Inc (LAB)
2.15
-0.11
(-4.87%)
USD |
NASDAQ |
Jun 14, 16:00
2.155
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Enterprise Value: 388.00M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 388.00M |
| June 13, 2024 | 428.69M |
| June 12, 2024 | 454.59M |
| June 11, 2024 | 465.69M |
| June 10, 2024 | 484.18M |
| June 07, 2024 | 450.89M |
| June 06, 2024 | 524.87M |
| June 05, 2024 | 543.37M |
| June 04, 2024 | 528.57M |
| June 03, 2024 | 510.08M |
| May 31, 2024 | 510.08M |
| May 30, 2024 | 539.67M |
| May 29, 2024 | 558.17M |
| May 28, 2024 | 528.57M |
| May 24, 2024 | 532.27M |
| May 23, 2024 | 558.17M |
| May 22, 2024 | 550.77M |
| May 21, 2024 | 547.07M |
| May 20, 2024 | 547.07M |
| May 17, 2024 | 543.37M |
| May 16, 2024 | 517.47M |
| May 15, 2024 | 534.19M |
| May 14, 2024 | 537.91M |
| May 13, 2024 | 515.58M |
| May 10, 2024 | 485.81M |
| Date | Value |
|---|---|
| May 09, 2024 | 489.53M |
| May 08, 2024 | 426.27M |
| May 07, 2024 | 474.65M |
| May 06, 2024 | 515.58M |
| May 03, 2024 | 526.75M |
| May 02, 2024 | 537.86M |
| May 01, 2024 | 541.60M |
| April 30, 2024 | 519.18M |
| April 29, 2024 | 532.25M |
| April 26, 2024 | 517.09M |
| April 25, 2024 | 486.78M |
| April 24, 2024 | 509.52M |
| April 23, 2024 | 562.56M |
| April 22, 2024 | 554.98M |
| April 19, 2024 | 547.40M |
| April 18, 2024 | 554.98M |
| April 17, 2024 | 581.50M |
| April 16, 2024 | 619.39M |
| April 15, 2024 | 642.12M |
| April 12, 2024 | 649.69M |
| April 11, 2024 | 695.16M |
| April 10, 2024 | 668.64M |
| April 09, 2024 | 703.44M |
| April 08, 2024 | 688.22M |
| April 05, 2024 | 634.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-57.79M
Minimum
Sep 29 2022
985.09M
Maximum
Mar 28 2024
302.84M
Average
308.74M
Median
Feb 07 2022
Enterprise Value Benchmarks
| Bruker Corp | 10.45B |
| Azenta Inc | 2.085B |
| Harvard Bioscience Inc | 157.08M |
| Bionano Genomics Inc | 33.67M |
| Akoya Biosciences Inc | 123.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.16M |
| Revenue (Quarterly) | 45.54M |
| Total Expenses (Quarterly) | 84.28M |
| EPS Diluted (Quarterly) | -0.27 |
| Gross Profit Margin (Quarterly) | 53.11% |
| Profit Margin (Quarterly) | -70.61% |
| Earnings Yield | -46.98% |
| Normalized Earnings Yield | -40.83 |